Latest Strategy Changes News

Syrah Resources resumed graphite production at its Balama mine and advanced its Vidalia anode material facility amid supportive US trade tariffs and tax credits, positioning itself strongly in the growing EV battery market.

Alliance Nickel has appointed financial advisors to explore a SPAC transaction for a Nasdaq listing, aiming to tap into premium US capital markets for its NiWest Nickel-Cobalt Project. The move follows a robust feasibility study and a strategic partnership with automaker Stellantis.

Liontown Resources reported a robust September quarter, doubling underground ore output and strengthening its balance sheet to $420 million. The company’s FY26 guidance confirms a strategic shift to underground mining with anticipated cost improvements.

Breakthrough Minerals reports encouraging soil sampling results at its Errolls Gold Project in Western Australia, setting the stage for imminent reverse circulation drilling. The company maintains a solid cash position of approximately AUD 1.68 million to support exploration activities.

Auris Minerals advances its exploration efforts in Western Australia's Bryah Basin with a $3.2 million strategic placement, aiming to expand its geological team and accelerate copper, gold, and rare earth project identification.

The Calmer Co has reported a robust 26% increase in quarterly sales, driven by strong growth in Australia and the US, alongside a significant 39% reduction in cash used in operations, signaling clear progress toward profitability.

The Calmer Co. International Limited has delivered its strongest quarter yet, with revenue surging 26% to $2.4 million and operating cash outflows dropping to a historic low. Strategic growth across retail, e-commerce, and B2B channels underpins its confident path to breakeven.

Gale Pacific reports stabilising trading conditions in Q1 FY26 with a strategic U.S. operating model overhaul delivering significant cost savings, despite a slight dip in overall sales.

Microba Life Sciences reports robust Q1 FY26 growth in microbiome diagnostics, introduces workflow-enhancing features, and prepares for key therapeutic deal catalysts by year-end.

IODM Limited has reported a record-breaking first quarter for FY26, with cash receipts soaring 76% year-on-year, driven predominantly by explosive growth in its UK Education segment. The company also made strategic advances in North America and Japan, setting the stage for broader global expansion.

Microba Life Sciences reports a 145% jump in core microbiome test volumes and is on track to achieve regional break-even by FY26, supported by strategic cost cuts and a $14.5 million capital raise.

Hillgrove Resources has accelerated production at its Nugent centre ahead of schedule, driving an 8% rise in copper output and reducing costs. A $28 million capital raise will fund further development and exploration, underpinning growth prospects.